Inhibiting RAP80 expression can upregulate the protein expression of Caspase-3, Apaf-1, cyt c, Bax and Fas; induce the apoptosis of breast cancer cells; and increase their chemosensitivity to cisplatin [63]. Here, BAX is linked to breast cancer.